Cepheid's Q4 Revenues Rise 19 Percent on Strong Consumables Sales | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its fourth-quarter revenues increased 19 percent on strong consumables sales. The firm also turned a profit, which was not expected by Wall Street.

Cepheid brought in total revenues of $58.7 million for the three months ended Dec. 31, compared to revenues of $49.2 million for the fourth quarter of 2009. Analysts, on average, had expected $56.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.